
Opinion|Videos|January 31, 2025
Current and emerging treatments for PPD
Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how postpartum depression treatments are evolving beyond traditional antidepressants to include rapid-acting options like brexanolone and zuranolone, along with enhanced screening and support programs for new mothers.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Accelerated FDA Action for Psychedelics: Insights From Daniel R. Karlin, MD, MA
2
FDA Approves sNDA of Caplyta for the Prevention of Relapse in Schizophrenia
3
FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder
4
A Review of Data on AXS-05 for Alzheimer Disease Agitation in Advance of Next Week's PDUFA Date
5





